Jul 17, 2024
Is the development of software eligible for funding under the Research Allowance Act?
The development of software can be eligible for funding under the Research Allowance Act (FZLG). However, this is a complex process that requires precise delineation.
In principle, software development projects that involve genuine research and development work can be funded. This includes innovative solutions and technological advancements that go beyond the current state of the art.
However, software developments that are limited to standard applications or the support of existing systems are not eligible for funding. These activities are considered routine developments and not research and development projects within the meaning of the FZLG.
For companies, this means that a thorough examination and documentation of project contents is necessary to determine eligibility for funding.
At Innoscripta, we have already successfully obtained approval for numerous projects and therefore possess extensive experience and expertise in this field. Let us advise you to optimally utilize your funding opportunities.
You Might Also Like
Jun 10, 2025
Cabinet draft provides for 20% flat-rate surcharge and increased funding cap for R&D tax incentive starting in 2026
On 4 June 2025, the German Federal Cabinet adopted a draft bill for an investment stimulus package. Among the proposed measures are changes to the R&D tax incentive scheme, expected to come into force in 2026:Introduction of a 20% flat-rate overhead surcharge on eligible R&D expenditures under the tax incentive,Increase in the annual funding cap from €10 million to €12 million per company.Both measures are intended to apply to R&D projects starting on or after 1 January 2026, and are currently scheduled to run until 2030. If adopted in its current form, the legislation could result in a higher average funding volume per client based on Innoscripta SE’s existing customer base. This creates a potential for additional revenue within the current business field, without requiring a broader client base. As the bill is still in draft form and must pass through both the Bundestag and Bundesrat, no final assessment of its economic impact can be made at this time. Innoscripta SE will continue to monitor the legislative process closely. About Innoscripta SEInnoscripta SE is a leading provider of cloud-based software solutions for research-related funding programs. Through its platform Clusterix, the company supports over 1,700 businesses with the application, documentation, and management of Germany’s R&D tax incentive. Innoscripta SE has been listed in the Scale segment of the Frankfurt Stock Exchange since May 2025 (Ticker: 1INN). Contact:Innoscripta SE · Arnulfstraße 60 · 80335 Munichpresse@innoscripta.com · www.innoscripta.com
Jun 17, 2025
Founders Plan Selective Share Purchases to Support Share Price
Munich, June 17, 2025 — The two primary innoscripta SE shareholders, Michael Hohenester (through Hohenester Beteiligungs-UG) and Alexander Meyer (through Meyer Beteiligungs-UG), have announced their intention to purchase a limited number of innoscripta SE shares through the stock exchange. The total volume is planned to be up to €12 million, with €10 million from Hohenester Beteiligungs-UG and €2 million from Meyer Beteiligungs-UG.The acquired shares are subject to existing lock-up obligations and may be sold no earlier than after the respective periods following the IPO have expired. Any subsequent sale will only be considered if there is a substantial and sustained recovery in the share price compared to the IPO placement price of €120. Attention will be paid to a market-compatible increase in the free float.This initiative is exclusively financed from the shareholders’ private funds and demonstrates their long-term confidence in innoscripta SE’s business model and prospects.
